Corient Private Wealth’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.54M Buy
11,319
+9,146
+421% +$1.12M ﹤0.01% 1546
2026
Q1
$252K Sell
2,173
-1,223
-36% -$171K ﹤0.01% 2420
2025
Q4
$558K Sell
3,396
-904
-21% -$142K ﹤0.01% 1812
2025
Q3
$575K Buy
4,300
+628
+17% +$76.3K ﹤0.01% 1718
2025
Q2
$457K Buy
3,672
+52
+1% +$6.62K ﹤0.01% 1750
2025
Q1
$461K Buy
3,620
+339
+10% +$52.2K ﹤0.01% 1638
2024
Q4
$472K Sell
3,281
-405
-11% -$58.1K ﹤0.01% 1654
2024
Q3
$549K Sell
3,686
-2,220
-38% -$318K ﹤0.01% 1687
2024
Q2
$745K Sell
5,906
-1,221
-17% -$191K ﹤0.01% 1455
2024
Q1
$1.31M Buy
7,127
+116
+2% +$22.1K ﹤0.01% 1219
2023
Q4
$1.26M Buy
7,011
+1,532
+28% +$238K ﹤0.01% 1201
2023
Q3
$872K Buy
5,479
+2,918
+114% +$477K ﹤0.01% 1245
2023
Q2
$362K Sell
2,561
-1,613
-39% -$259K ﹤0.01% 1615
2023
Q1
$705K Buy
4,174
+883
+27% +$158K ﹤0.01% 1229
2022
Q4
$551K Buy
+3,291
New +$597K ﹤0.01% 1109

Other funds holding RGEN

Corient Private Wealth's RGEN Position: Q2 2026 in Review

Corient Private Wealth increased its Repligen (RGEN) stake by 421% in Q2 2026, buying an estimated $1.12M and bringing the position to 11,319 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #1546.

Corient Private Wealth first reported a position in RGEN in Q4 2022 and has held it in 15 quarters since. 481 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Corient Private Wealth held 11,319 shares of Repligen worth $1.54M as of Q2 2026.
  • Corient Private Wealth bought 9,146 Repligen shares in Q2 2026, an estimated $1.12M.
  • Repligen made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1546 holding.
  • Corient Private Wealth first reported a position in Repligen in Q4 2022 and has held it in 15 quarters since.
  • 481 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.